Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We use our state-of-the-art dedicated workflow for designing focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The method includes detailed molecular simulations of the catalytic and allosteric binding pockets, along with ensemble virtual screening that considers their conformational flexibility. In the design of modulators, structural changes induced by reaction intermediates are taken into account to enhance activity and selectivity.
Key features that set our library apart include:
partner
Reaxense
upacc
Q96KP4
UPID:
CNDP2_HUMAN
Alternative names:
CNDP dipeptidase 2; Glutamate carboxypeptidase-like protein 1; Peptidase A; Threonyl dipeptidase
Alternative UPACC:
Q96KP4; B3KUG4; Q8WY59; Q9BQ94; Q9NVB4; V9HWE5
Background:
Cytosolic non-specific dipeptidase, also known as CNDP dipeptidase 2, plays a crucial role in peptide bond hydrolysis, specifically targeting threonyl dipeptides. This enzyme exhibits a unique activity towards cysteinylglycine, a key intermediate in glutathione metabolism, and is involved in the catabolism of N-lactoyl-amino acids. Its ability to regulate cell cycle arrest and apoptosis underscores its importance in cellular processes.
Therapeutic significance:
Understanding the role of Cytosolic non-specific dipeptidase could open doors to potential therapeutic strategies. Its involvement in glutathione metabolism and cell cycle regulation presents an opportunity for targeted interventions in diseases where these pathways are dysregulated.